Search for Clinical Trials
Utilization of a Mindfulness Smartphone Application Among High Risk Pregnant Women to Reduce Perceived Stress and Improve Other Markers of Mental…
A multicenter, double-masked, randomized, vehicle-controlled 12-month (with a 12-month, double-masked extension) parallel comparison of the safety…
ROMA:WOMEN is a prospective un-blinded randomized multicenter clinical trial. Patients will be randomized to a single arterial graft (SAG) or…
An extension of studies to evaluate Abbv-951 in subjects with advanced Parkinson's disease (H-52937)
Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
A multicenter, open-label, study to evaluate the long-term safety of ecopipam tablets in children, adolescents and adults with Tourette's disorderThe…
Sage Therapeutics, Inc. is sponsoring this study of an investigational drug called SAGE-718. SAGE-718 is being evaluated for possible…
A multicenter, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of ecopipam in…
A 17-Week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, multicenter study of the efficacy and safety of…
The purpose of this study is to find out how safe and effective the new drug, AMX0035, is for the treatment of PSP and to determine if AMX0035 can…
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's diseaseThe purpose of this study…
